175 related articles for article (PubMed ID: 14067239)
1. FALLACIES OF GENERIC EQUIVALENCE THESIS. I. SOME PHYSIOLOGIC FACTORS INFLUENCING GASTROINTESTINAL ABSORPTION.
DELGADO JN; COSGROVE FP
Tex State J Med; 1963 Oct; 59():1008-12. PubMed ID: 14067239
[No Abstract] [Full Text] [Related]
2. FALLACIES OF GENERIC EQUIVALENCE THESIS. II. PHYSICO-CHEMICAL AND PHARMACEUTIC FACTORS AFFECTING GASTROINTESTINAL ABSORPTION.
DELGADO JN; COSGROVE FP
Tex State J Med; 1963 Nov; 59():1106-12. PubMed ID: 14084906
[No Abstract] [Full Text] [Related]
3. Therapeutic non-equivalence.
Br Med J; 1972 Sep; 3(5827):599-600. PubMed ID: 5071688
[No Abstract] [Full Text] [Related]
4. [Pharmacology and practical therapy. Principles for the selection of application form of a drug and its mode of origin].
Levy G; Barr WH
Internist (Berl); 1973 Dec; 14(12):661-7. PubMed ID: 4593013
[No Abstract] [Full Text] [Related]
5. The effect of dosage form upon the gastrointestinal absorption rate of salicylates.
LEVY G; GUMTOW RH; RUTOWSKI JM
Can Med Assoc J; 1961 Aug; 85(8):414-9. PubMed ID: 13761602
[No Abstract] [Full Text] [Related]
6. Equipment and methodology for relating gastrointestinal absorption to site of drug release.
ERIKSEN SP; SWINTOSKY JV; SERFASS EJ; LIN TH; ABRAMS J; STURTEVANT FM
J Pharm Sci; 1961 Feb; 50():151-6. PubMed ID: 13697149
[No Abstract] [Full Text] [Related]
7. Pharmaceutical properties of drugs and dosage forms affecting physiological availability.
Lachman L; Roemer WC
J Am Pharm Assoc; 1972 May; 12(5):215-24. PubMed ID: 5020412
[No Abstract] [Full Text] [Related]
8. Generic-therapeutic equivalence--enigma or myth?
Shirkey HC
Hawaii Med J; 1970; 29(3):201-2. PubMed ID: 5416016
[No Abstract] [Full Text] [Related]
9. STUDIES ON THE GASTRO-INTESTINAL ABSORPTION OF PURIFIED SODIUM CARBOXYMETHYLCELLULOSE.
FRAWLEY JP; WIEBE AK; KLUG ED; SHELANSKI MV
Food Cosmet Toxicol; 1964 Nov; 2():539-43. PubMed ID: 14249970
[No Abstract] [Full Text] [Related]
10. Pharmaceutical applications of AC biosusceptometry.
Corá LA; Américo MF; Romeiro FG; Oliveira RB; Miranda JR
Eur J Pharm Biopharm; 2010 Jan; 74(1):67-77. PubMed ID: 19482083
[TBL] [Abstract][Full Text] [Related]
11. [Chemical equivalency and therapeutic non-equivalency of drugs in pharmaceutical forms of different formulation].
Borasi M
Boll Chim Farm; 1973 Jan; 112(1):1-5. PubMed ID: 4710257
[No Abstract] [Full Text] [Related]
12. Development of a continuous dissolution/absorption system--a technical note.
Gao Z
AAPS PharmSciTech; 2012 Dec; 13(4):1287-92. PubMed ID: 22996672
[No Abstract] [Full Text] [Related]
13. Evolution of a detailed physiological model to simulate the gastrointestinal transit and absorption process in humans, part II: extension to describe performance of solid dosage forms.
Thelen K; Coboeken K; Willmann S; Dressman JB; Lippert J
J Pharm Sci; 2012 Mar; 101(3):1267-80. PubMed ID: 22125236
[TBL] [Abstract][Full Text] [Related]
14. Impact of Pharmaceutical Excipients on Oral Drug Absorption: A Focus on Intestinal Drug Transporters.
Zou L; Ni Z; Tsakalozou E; Giacomini KM
Clin Pharmacol Ther; 2019 Feb; 105(2):323-325. PubMed ID: 30663035
[No Abstract] [Full Text] [Related]
15. BIOPHARMACEUTICS: GASTROINTESTINAL ABSORPTION ASPECTS.
WAGNER JG
Antibiot Chemother; 1964; 12():53-84. PubMed ID: 14262407
[No Abstract] [Full Text] [Related]
16. Confounding factors for sex differences in pharmacokinetics and pharmacodynamics: focus on dosing regimen, dosage form, and formulation.
Chen ML
Clin Pharmacol Ther; 2005 Oct; 78(4):322-9. PubMed ID: 16198651
[No Abstract] [Full Text] [Related]
17. Gastrointestinal absorption II. Formulation factors affecting drug bioavailability.
Blanchard J
Am J Pharm Sci Support Public Health; 1978; 150(5):132-51. PubMed ID: 364993
[No Abstract] [Full Text] [Related]
18. Effect of particle size on dissolution and gastrointestinal absorption rates of pharmaceuticals.
LEVY G
Am J Pharm Sci Support Public Health; 1963 Mar; 135():78-92. PubMed ID: 13930259
[No Abstract] [Full Text] [Related]
19. PBPK models for the prediction of in vivo performance of oral dosage forms.
Kostewicz ES; Aarons L; Bergstrand M; Bolger MB; Galetin A; Hatley O; Jamei M; Lloyd R; Pepin X; Rostami-Hodjegan A; Sjögren E; Tannergren C; Turner DB; Wagner C; Weitschies W; Dressman J
Eur J Pharm Sci; 2014 Jun; 57():300-21. PubMed ID: 24060672
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic simulation of biowaiver criteria: the effects of gastric emptying, dissolution, absorption and elimination rates.
Kortejärvi H; Urtti A; Yliperttula M
Eur J Pharm Sci; 2007 Feb; 30(2):155-66. PubMed ID: 17187967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
